Advancing Biomarker Validation for Drug Hypersensitivity
Physician's Weekly
JUNE 16, 2025
Biomarkers for drug-induced immune reactions aid clinicians in diagnosing, risk-stratifying, and managing diseases. But the varied mechanisms and clinical presentations of drug hypersensitivity reactions (DHRs) can make diagnosis and treatment challenging, and most biomarkers still require validation.
Let's personalize your content